The Impact of the Pandemic Experience on Future Vaccine-Related Intentions and Behaviours (2022) - Executive Summary

Prepared for the Public Health Agency of Canada

Supplier name: Earnscliffe Strategy Group
Contract number: CW2244294-6D145-225103
Contract value: $171,545.30 (including applicable taxes)
Award date: October 12, 2022
Delivery date: January 20, 2023

Registration number: POR 062-22
For more information on this report, please contact the Public Health Agency of Canada at: hc.cpab.por-rop.dgcap.sc@canada.ca

Ce rapport est aussi disponible en français.

The Impact of the Pandemic Experience on Future Vaccine-Related Intentions and Behaviours (2022) - Executive Summary

Prepared for the Public Health Agency of Canada

Supplier name: Earnscliffe Strategy Group
January 2023

This public opinion research report presents the results of an online survey and focus groups conducted concurrently by Earnscliffe Strategy Group on behalf of the Public Health Agency of Canada. The fieldwork for the qualitative research was conducted in November 2022 and in December 2022 for the quantitative research.

Cette publication est aussi disponible en français sous le titre : L'impact de l'expérience de la pandémie de COVID-19 sur les intentions et les comportements futurs liés aux vaccins (2022).

This publication may be reproduced for non-commercial purposes only. Prior written permission must be obtained from the Public Health Agency of Canada. For more information on this report, please contact the Public Health Agency of Canada at: hc.cpab.por-rop.dgcap.sc@canada.ca or at:

Public Health Agency of Canada
130 Colonnade Rd.
A.L. 6501H
Ottawa, Ontario K1A 0K9

Catalogue Number: H14-432/2023E-PDF

International Standard Book Number (ISBN): 978-0-660-47667-4

Related publications (registration number): H14-432/2023F-PDF

L'impact de l'expérience de la pandémie de COVID-19 sur les intentions et les comportements futurs liés aux vaccins (2022) (Final Report, French) ISBN 978-0-660-47668-1

© His Majesty the King in Right of Canada, as represented by the Minister of Health, 2023

Executive summary

Earnscliffe Strategy Group (Earnscliffe) is pleased to present this report to the Public Health Agency of Canada (PHAC) summarizing the results of quantitative and qualitative research undertaken to understand the impact of the pandemic experience on future vaccine-related intentions and behaviours.

Vaccines are a core public health tool to protect the population's health. Public sentiment around COVID-19 vaccines has been even more dynamic and rapidly changing than with other vaccines, reflecting evolving epidemiology and anxieties about the newness of COVID-19 vaccines and emerging variants, reported risks of side-effects, misinformation circulating, vaccine and public health measure fatigue, and increased distrust of government and science.

Research prior to the pandemic established various key factors and determinants that impacted vaccine confidence and resulting vaccine behaviours. However, the pandemic experience has been novel to this generation and has necessitated the general population to engage with intense and ongoing adaptation. The consequences of this burden are still unknown and as society transitions towards recovery, it was critical that PHAC gain insight into how these events are processed and what this might mean for vaccine confidence (that is, routine and/or boosters for COVID-19) going forward.

To that end, the primary objective of this research was to provide PHAC with insights into Canadians' overall awareness, perceptions, and concerns about the impacts of the COVID-19 pandemic, including mental health impacts, government relief efforts and expectations, recovery, public health measures, and vaccines in order to develop targeted communications strategies and products. The contract value for this project was $171,545.30 including HST.

To meet the current objectives, Earnscliffe conducted a two-phased research program involving both quantitative and qualitative research that ran concurrently.

The quantitative phase involved an online survey of 2,088 Canadians aged 18 and older. The online survey was conducted using Leger's opt-in panel between December 1 and 6, 2022. The online survey was completed in either English or French and took an average of 16 minutes to complete.

Respondents for the online survey were selected from among those who have volunteered to participate in online surveys. The data was weighted to reflect the demographic composition of the Canadian population aged 18 and older. Because the online sample is based on those who initially self-selected for participation in the panel, no estimates of sampling error can be calculated, and the results cannot be described as statistically projectable to the target population. The treatment here of the non-probability sample is aligned with the Standards for the Conduct of Government of Canada Public Opinion Research - Online Surveys. Appendix A provides full details on the survey methodology and Appendix C provides the survey instrument used.

At the same time, qualitative research was undertaken, which included a series of sixteen (16) focus groups between November 21 and 24, 2022 with adults aged 18 and older, adults 18-39, Indigenous adults aged 18 and older who live off-reservation, and health care professionals. A maximum of ten (10) individuals were recruited for each group. In total, 144 people participated in the focus group discussions. One discussion group among each target audience was conducted with residents of Atlantic Canada (Newfoundland, Prince Edward Island, Nova Scotia, New Brunswick), Quebec, Ontario, and the West/North (Manitoba, Saskatchewan, Alberta, British Columbia, Yukon, Northwest Territories, Nunavut). Those living in official language minority communities (OLMCs) were invited to participate in a group in their preferred language at a date and time that was convenient to them. The sessions were approximately 90 minutes in length.

It is important to note that qualitative research is a form of scientific, social, policy, and public opinion research. Focus group research is not designed to help a group reach a consensus or to make decisions, but rather to elicit the full range of ideas, attitudes, experiences, and opinions of a selected sample of participants on a defined topic. Because of the small numbers involved, the participants cannot be expected to be thoroughly representative in a statistical sense of the larger population from which they are drawn, and findings cannot reliably be generalized beyond their number. As such, results are directional only.

The key findings from the research are presented below.

Key quantitative findings

Key qualitative findings

Research firm: Earnscliffe Strategy Group (Earnscliffe)
Contract number: CW2244294-6D145-225103
Contract value: $171,545.30 (including applicable taxes)
Contract award date: October 12, 2022

I hereby certify as a representative of Earnscliffe Strategy Group that the final deliverables fully comply with the Government of Canada political neutrality requirements outlined in the Communications Policy of the Government of Canada and Procedures for Planning and Contracting Public Opinion Research. Specifically, the deliverables do not include information on electoral voting intentions, political party preferences, standings with the electorate or ratings of the performance of a political party or its leaders.

Signed: Stephanie Constable, Principal, Earnscliffe

Date: January 20, 2023